Amgen Inc. vs Johnson & Johnson — Stock Comparison
Q·Score Breakdown
7.2
Buy
Overall
7.1
Buy
Quality
Health
Growth
Valuation
Sentiment
AMGN
High-quality business with 106% return on equity and 21% profit margins.
⚠ high leverage at 6.4× debt-to-equity.
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
Analyst Consensus
HOLD
Target $352.73 (+1.2%)
30 analysts
BUY
Target $252.42 (+9.9%)
24 analysts
Fundamentals
AMGN
JNJ
24.5×
Trailing P/E
26.6×
14.9×
Forward P/E
18.1×
21.0%
Profit Margin
21.8%
70.8%
Gross Margin
68.0%
106.1%
ROE
26.4%
8.6%
Revenue Growth
9.9%
112.1%
Earnings Growth
-52.9%
0.47
Beta
0.33
—
Price / Book
—
$187.9B
Market Cap
$552.9B
$261 – $391
52-Week Range
$146 – $252
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.